Introduction
People with cystic fibrosis (CF) are at risk of contracting Pseudomonas aeruginosa and other potentially harmful organisms from the environment.1 The Cystic Fibrosis Trust consider tropical fish tanks to be a risk only if the patient is in direct contact with the water.1 We report a boy with CF who at 11 months isolated Pseudomonas species identified as mucoid Aeromonas hydrophila, non-mucoid Aeromonas hydrophila and Pseudomonas aeruginosa from cough swabs. We believe he became infected by aerosol spread of the bacterium secondary to the aeration process in fish tanks in his home. Isolations only ceased on removal of the tanks from the home.
The patient was born at term after antenatal detection of echogenic bowel at 20 weeks gestation. There were no neonatal concerns and genetic testing confirmed the diagnosis of CF (homozygous ΔF508). He was started on routine CF treatment including flucloxacillin. He has had numerous microbiological isolations, all from cough swabs (Table 1).
Table 1.
A summary of the child’s microbiological isolations from cough swabs
Age (months) | Symptoms (Yes / No) | Organism | Treatment at time of swab | New treatment |
---|---|---|---|---|
2 | Yes | Haemophilus influenzae | Nil | Augmentin |
5 | Yes | Klebsiella species | Nil | Ciprofloxacin |
6 | No | URT flora | Nil | Nil |
7 | No | Non-mucoid Pseudomonas species | Nil | Ciprofloxacin + Colomycin |
8 | No | Non-mucoid Pseudomonas species | Ciprofloxacin + Colomycin | Continued |
9 | No | URT flora | Ciprofloxacin + Colomycin | Colomycin only |
10 | No | URT flora | Colomycin | Stopped |
11 | Yes | Mucoid Pseudomonas species* | Nil | Ciprofloxacin + Colomycin |
12 | No | Non-mucoid Pseudomonas species, E. coli | Ciprofloxacin + Colomycin | Continued |
13 | No | URT flora | Colomycin | Continued |
14 | No | Non-mucoid Pseudomonas species | Colomycin | Ciprofloxacin + Colomycin |
15 | No | URT flora | Colomycin | Continued |
16 | No | URT flora | Colomycin | Stopped |
18 | No | URT flora | Nil | Nil |
20 | No | URT flora | Nil | Nil |
24 | No | URT flora | Nil | Nil |
Three bacteria identified on culture: Mucoid + non-mucoid Aeromonas hydrophila, and non-mucoid Psudomonas aeruginosa
URT, upper respiratory tract
Before six months of age he had two episodes of symptomatic cough and he grew two different organisms. He was asymptomatic at seven months when a fully sensitive, non-mucoid Pseudomonas species was isolated from a cough swab. Despite treatment with ciprofloxacin and colomycin nebulizers, the same organisms were identified three weeks later (asymptomatic). Treatment was stopped at 10 months after two clear cough swabs.
At 11 months of age he developed a productive cough and this time grew a fully sensitive mucoid Pseudomonas species. He was restarted on ciprofloxacin and colomycin and an extended microbiological identification was requested. This revealed three different bacteria: a mucoid A. hydrophila type 1, a non-mucoid A. hydrophila type 2 and a non-mucoid P. aeruginosa. Chest X ray was normal and symptoms responded promptly to treatment but a Pseudomonas species grew again after one month. His home environment was reviewed as he had isolated a type of organism that usually inhabits aquatic environments. Our CF nurse had visited his home on several occasions: she reported that the family had four large fish tanks in their living room, and had expressed concerns that these may be the cause of the patient's infections. The tanks had oxygen pumps and appeared poorly maintained (the tank water was very cloudy). The family were advised to have the tanks removed, and after discussion they were removed when the patient was 15 months old. At the time of writing, nine months after the tanks were removed, repeated cough swabs have been clear.
Discussion
Our case highlights the risk associated with fish tanks in the home environment. We believe the risk is greater than previously described.1 A. hydrophila infection has not been described as a cause of symptoms in CF. It is a facultative anaerobic Gram-negative bacillus and is a member of the same family as P. aeruginosa. The natural habitat is fresh or brackish water and it has been implicated in the aetiology of various diseases in fish. In adults it can cause gastroenteritis if swallowed, wound infection if the penetrating injury has occurred in freshwater and septicaemia.2 It is also a recognized cause of pneumonia and lung abscess in patients who have aspirated contaminated water associated with near-drowning.3
Other Gram-negative bacteria can spread to humans by droplet inhalation, notably Legionella pneumophila. Patient-to-patient transmission of P. aeruginosa is well recognized in the CF population. Home nebulizers may also play a role in transmitting potential pathogens and home inhalation equipment can harbour P. aeruginosa.4 One important study looking at risk factors for early acquisition of P. aeruginosa found that early use of nebulizers was one of the most significant risk factors for early infection.5
The aerosol pathway of Aeromonas salmonicida has been investigated.6 The source was an infected tank of water containing an air diffuser and A. salmonicida was shown to travel over one metre from its source and remain viable. A. salmonicida has been isolated from sputum of adult patients with CF.7
The oxygen pump at the bottom of a commercial tank produces bubbles that rise up through the water. If this water is infected with A. hydrophila, aerosols released at the water surface contain these bacteria. These droplets could be inhaled directly or settle on surfaces. At seven months of age our infant spent most of his day in the family living room. The most likely explanation of infection is that he inhaled viable bacteria that had been transmitted from the tank to his immediate environment.
In conclusion, fish tanks are a more significant risk in CF then currently acknowledged. It is important to ask about fish tanks at clinic appointments, especially if there is recurrent isolation of a Gram-negative species. We feel families should be made aware that fish tanks can be a source of organisms including P. aeruginosa, and that anyone with CF may be at increased risk. If families choose to keep fish, the tank should be maintained and cleaned regularly and kept covered at all times, and all unhealthy fish should be removed promptly.
Footnotes
DECLARATIONS —
Competing interests None declared
Funding None
Ethical approval Not applicable
Guarantor DC
Contributorship Both authors contributed equally
Acknowledgements
We wish to thank Mrs Cathy Mckenny, Cystic Fibrosis Sister, who visited the family on numerous occasions and who was the first to suggest a possible link between the child's illness and the fish tanks
References
- 1.Littlewood J. The environment as a source of Pseudomonas aeruginosa and some other potential CF pathogens. London: Cystic Fibrosis Trust; 2007. www.cftrust.org.uk/aboutcf/publications/Pseudomonas_article_-_Jim__Sept_07_.pdf. [Google Scholar]
- 2.Jones BL, Wilcox MH. Aeromonas infections and their treatment. J Antimicrob Chemother. 1995;35:453–61. doi: 10.1093/jac/35.4.453. [DOI] [PubMed] [Google Scholar]
- 3.Reines HD, Cook FV. Pneumonia and bacteremia due to Aeromonas hydrophila. Chest. 1981;80:264–7. doi: 10.1378/chest.80.3.264. [DOI] [PubMed] [Google Scholar]
- 4.Pitchford KCM, Corey AK, Highsmith R, et al. Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment. J Pediatr. 1987;111:212–6. doi: 10.1016/s0022-3476(87)80069-0. [DOI] [PubMed] [Google Scholar]
- 5.Kosorok MR, Jalaluddin M, Farrell PM, et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol. 1998;26:81–8. doi: 10.1002/(sici)1099-0496(199808)26:2<81::aid-ppul2>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
- 6.Wooster GA, Bowser PR. The aerobiological pathway of a fish pathogen:survival and dissemination of Aeromonas salmonicida in aerosols and its implication in fish health management. J World Aquaculture Soc. 1996;27:7–14. [Google Scholar]
- 7.Gillow C, Shaw A, Moore JE, et al. Antibiotic resistance and identification of uncommon Gram-negative bacteria isolated from sputum of adult patients with cystic fibrosis. Br J Biomed Sci. 2006;63:22–5. doi: 10.1080/09674845.2006.11978085. [DOI] [PubMed] [Google Scholar]